Streetbeat News

Price Targets

ALT

HC Wainwright & Co. analyst Patrick Trucchio maintains a 'Buy' rating on Altimmune (NASDAQ:ALT) but has lowered the price target from $50 to $15.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 3:54 pm

TSHA

Cantor Fitzgerald analyst Kristen Kluska maintains an Overweight rating on Taysha Gene Therapies (NASDAQ:TSHA) and raises the price target from $2 to $7.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 3:26 pm

ARMP

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Armata Pharmaceuticals (AMEX:ARMP) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 3:10 pm

MIST

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Milestone Pharmaceuticals (NASDAQ:MIST) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 3:08 pm

RVNC

Needham analyst Serge Belanger has reiterated a 'Buy' rating on Revance Therapeutics (NASDAQ:RVNC) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 3:06 pm

PDSB

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on PDS Biotechnology (NASDAQ:PDSB) and maintained a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 3:05 pm

RPAY

Over the past 3 months, 5 analysts have published their opinion on Repay Hldgs (NASDAQ:RPAY) stock. The company has an average price target of $9.9 with a high of $12.00 and a low of $8.50. The average price target has increased by 16.47% over the past month.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 3:00 pm

TALO

Over the past 3 months, 5 analysts have published their opinion on Talos Energy (NYSE:TALO) stock. The analysts, typically employed by large Wall Street banks, have given 4 bullish and 1 somewhat bullish ratings. The average 12-month price target for Talos Energy is $21.6, representing a 6.09% decrease from the previous average price target of $23.00.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 3:00 pm

VALN

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Valneva (NASDAQ:VALN) and maintained a $22 price target.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 2:59 pm

TSX:SFTC

RBC Capital analyst Paul Treiber has reiterated a 'Sector Perform' rating on Softchoice (TSX:SFTC) and maintained a price target of C$19.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 2:56 pm